Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-11-28

Clinical Trial Update: Autologous Mesenchymal Stem Cells Transplantation in Cervical Chronic and Complete Spinal Cord Injury [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on autologous mesenchymal stem cell transplantation for cervical chronic and complete spinal cord injury, with the current status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous mesenchymal stem cell transplantation (Mesenchymal stem cells)

Snippet

Sponsor: Hospital Sao Rafael | Conditions: Spinal Cord Injury | Phase 1 | Status: UNKNOWN